Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Obesity influences esophageal function in GERD

A study published ahead of print in Alimentary Pharmacology & Therapeutics examines the effects of obesity on esophageal function, acid exposure and the symptoms of gastro-esophageal reflux disease.

News image

Obese patients have an increased risk of gastro-esophageal reflux disease; however, the mechanism underlying this association is uncertain.

Dr Anggiansah and colleagues examined the mechanical effects of obesity on esophageal function increase acid exposure and symptoms.

The team measured that height, weight and waist circumference in patients with typical reflux symptoms referred for manometry and 24 h ambulatory pH studies.

Symptom severity was assessed by questionnaire.

The research team evaluated the association between obesity, esophageal function, acid exposure and reflux symptoms was assessed.

Physiological measurements were obtained from 582 patients of whom 406 completed symptom questionnaires.

The team of doctors found that the prevalence of general obesity was greater in women, however more men had abdominal obesity.

Reflux symptoms increased with acid exposure
Alimentary Pharmacology & Therapeutics

The team noted that esophageal acid exposure increased with obesity, and was associated also with lower esophageal sphincter pressure, reduced abdominal lower esophageal sphincter length and peristaltic dysfunction.

The researchers showed a negative association with both lower esophageal sphincter pressure, and abdominal lower esophageal sphincter length.

However, multivariable analysis demonstrated that the effects of increasing waist circumference on esophageal function do not explain increased acid reflux in obese patients.

The team of doctors identified independent effects of obesity and esophageal dysfunction on acid exposure.

Reflux symptoms increased with acid exposure and this association explained increased symptom severity in obese patients.

Dr Anggiansah's team concluded, "Abdominal obesity is associated with esophageal dysfunction, increased acid exposure and reflux symptoms."

"However, this analysis does not support the mechanical hypothesis that the effects of obesity on esophageal function are the cause of increased acid exposure in obese patients."

Aliment Pharmacol Ther 2013
22 January 2013

Go to top of page Email this page Email this page to a colleague

 02 March 2015

Advanced search
 02 March 2015 
Liver disease in patients awaiting liver transplant
 02 March 2015 
Assessment of GERD
 02 March 2015 
Genes and early diagnosis of IBD
 27 February 2015 
Obesity and weight-loss therapy
 27 February 2015 
MRE performance in staging liver fibrosis
 27 February 2015 
Bleeding in diverticulosis
 26 February 2015 
Familial colorectal cancer risk and primary cancer
 26 February 2015 
Herbal products and the liver
 26 February 2015 
Questionnaires for GERD
 25 February 2015 
Exercise and NAFLD
 25 February 2015 
IBD in Korea
 25 February 2015 
Immunosuppressive therapy and T. whipplei
 24 February 2015 
Clinical trials in pediatric IBD
 24 February 2015 
Reducing health care costs in IBD
 24 February 2015 
GI bleeding after anticoagulation interruption
 23 February 2015 
Visceral abdominal obesity and IBS
 23 February 2015 
Crohn's outcomes with infliximab
 23 February 2015 
Intestinal microbiota and celiac disease
 20 February 2015 
H. pylori eradication
 20 February 2015 
Antiviral treatment and Hep C outcomes
 20 February 2015 
C. diff testing in IBD
 19 February 2015 
Intestinal microbiota in IBS
 19 February 2015 
Peptic ulcer bleeding mortality in liver disease
 19 February 2015 
Fecal microbial transplant in active Crohn's disease
 18 February 2015 
Genetic testing and GI cancers
 18 February 2015 
Placebo analgesia in functional abdominal pain
 18 February 2015 
Successful Hep C virus therapy
 17 February 2015 
Quality measures and colonoscopist selection
 17 February 2015 
Global incidence of esophageal cancer
 17 February 2015 
Anti-viral treatment and survival in Hep C
 16 February 2015 
Saliva for the diagnosis of GERD
 16 February 2015 
H pylori eradication therapy
 16 February 2015 
Medical marijuana for digestive disorders
 13 February 2015 
Prevalence of microscopic colitis
 13 February 2015 
Beta-blockers in cirrhosis
 13 February 2015 
Liver disease and peptic ulcer bleeding
 12 February 2015 
Liver disease in chronic Hep C
 12 February 2015 
Patient-reported outcomes in Hep C
 12 February 2015 
Patientsí colonoscopist selection
 11 February 2015 
Hepatic decompensation in Hep C cirrhosis
 11 February 2015 
NAFLD and CVD
 11 February 2015 
Guidelines for the diagnosis of hepatocellular carcinoma
 10 February 2015 
Percutaneous endoscopic gastrostomy
 10 February 2015 
Factors that influence hepatic steatosis
 10 February 2015 
Gene variants and Crohn's susceptibility
 09 February 2015 
Factors that influence gallstone surgery
 09 February 2015 
Factors associated with increased mortality in cirrhosis
 09 February 2015 
Use of immunomodulators in IBD
 06 February 2015 
Colorectal cancer risk in IBD
 06 February 2015 
H. pylori and peptic ulcer bleeding
 06 February 2015 
IBS and somatization
 05 February 2015 
GERD, dyspepsia and IBS symptoms
 05 February 2015 
Quality of life in Crohn's after antitumor necrosis factor agents
 05 February 2015 
Thalidomide and refractory Crohn's
 04 February 2015 
Telemedicine in IBD
 04 February 2015 
Infliximab and muscle wasting in Crohn's
 04 February 2015 
Resistance mutations in chronic Hep B
 03 February 2015 
Testosterone in advanced liver disease
 03 February 2015 
Mortality in peptic ulcer bleeding
 03 February 2015 
Colonoscopic remission of ulcerative colitis

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us